comparemela.com
Home
Live Updates
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data - Nurix Therapeutics (NASDAQ:NRIX) : comparemela.com
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data - Nurix Therapeutics (NASDAQ:NRIX)
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)
Related Keywords
Switzerland ,
Lugano ,
Ticino ,
Robert Burns ,
Mitchell Kapoor Raghuram Selvaraju ,
International Conference On Malignant Lymphoma ,
Merck Co Inc ,
Nurix Therapeutics ,
Nurix Therapeutic ,
International Conference ,
Malignant Lymphoma ,
Mitchell Kapoor ,
Raghuram Selvaraju ,
comparemela.com © 2020. All Rights Reserved.